LEXINGTON, Massachusetts, September 29, 2015 /PRNewswire/ --

Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Phil Vickers, Head of Research and Development and Jeff Poulton, Chief Financial Officer, will participate in the Leerink Partners 4th Annual Rare Disease Roundtable in New York City, NY on Wednesday, September 30, 2015, at 8:25 a.m. EDT (1:25 p.m. BST).

A live audio webcast will be available on the Presentations and Webcasts section of Shire's Investor website at http://investors.shire.com/presentations-and-webcasts/year-2015.aspx. Subsequently, a replay of the webcast will be available on this same website for approximately 90 days.

NOTES TO EDITORS

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.

http://www.shire.com

        
         
        For further information please contact: 
        EmptyBreak:MARKER 
        Matt Osborne 
        mattosborne@shire.com 
        +1-781-482-9502 
        EmptyBreak:MARKER 
        Sarah Elton-Farr 
        seltonfarr@shire.com 
        +44-1256-894157 

 

SOURCE Shire plc